Status:

COMPLETED

Evaluation of Patient Education in Irritable Bowel Syndrome

Lead Sponsor:

Sorlandet Hospital HF

Collaborating Sponsors:

Sykehuset Telemark

The Hospital of Vestfold

Conditions:

Irritable Bowel Syndrome

Eligibility:

All Genders

18-70 years

Phase:

PHASE3

Brief Summary

About 10% of the population in western countries suffer from abdominal pain and change of bowel habits - known as the irritable bowel syndrome. The patients suffer from low quality of life and they ar...

Detailed Description

The patients are enrolled in endoscopic clinics in 7 hospitals in Norway. They are randomized to receive intervention now (intervention group) or in 6 months (control group). The intervention is a 6 h...

Eligibility Criteria

Inclusion

  • A diagnosis of Irritable Bowel Syndrome, verified by the Rome II criteria
  • Must be able to participate in a education-group

Exclusion

  • Another GI-diagnosis or kind of surgery that may interfere with the symptoms of irritable bowel syndrome
  • Serious, untreated psychiatric disorder

Key Trial Info

Start Date :

January 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2008

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT00305968

Start Date

January 1 2006

End Date

January 1 2008

Last Update

December 21 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sorlandet Sykehus HF

Kristiansand, Norway, 4633

Evaluation of Patient Education in Irritable Bowel Syndrome | DecenTrialz